Related by context. All words. (Click for frequent words.) 75 advanced adenomas 74 advanced adenoma 71 malignant polyps 71 colorectal adenoma 70 HGPIN 70 renal cell carcinomas 69 adenoma 69 colorectal neoplasms 68 invasive ductal 68 metastatic lesions 68 thyrotropin levels 68 #.#ng/ml 68 nonmelanoma skin cancers 68 axillary lymph nodes 68 elevated CRP 68 ductal cancer 68 ductal breast cancer 67 precancerous polyp 67 adenomatous polyps 67 specific antigen PSA 67 pre cancerous growths 67 metachronous 67 CIN3 67 colorectal polyps 67 colorectal tumors 67 coronary calcification 67 atypical hyperplasia 67 troponin T 67 extracapsular extension 66 basal cell carcinomas 66 adenomatous 66 invasive carcinomas 66 nodal metastasis 66 Rectal cancer 66 NP CRNs 66 histologic subtype 66 bowel cancers 66 HER2 expression 66 endometrial hyperplasia 66 hormone receptor negative 66 precursor lesions 66 serous ovarian cancer 66 bladder tumors 66 colorectal neoplasia 66 B7 H3 66 lobular carcinoma 66 hyperplastic polyps 65 colorectal carcinoma 65 distal colon 65 histopathologic examination 65 hamartomas 65 chlamydial infection 65 locoregional recurrence 65 CIN2 + 65 prostate carcinoma 65 polypoid lesions 65 polypoid 65 intestinal metaplasia 65 hyperplastic 65 carotid plaque 65 serum PSA 65 Colon polyps 65 serum homocysteine 65 bacteriuria 65 undergone radical prostatectomy 65 advanced neoplasia 65 thyroid nodules 65 endometrial tumors 65 lobular cancer 65 N telopeptide 65 proximal colon 65 intestinal polyps 65 nonsmall cell lung cancer 65 benign breast 65 distal colon cancer 65 subclinical hyperthyroidism 65 pre malignant lesions 65 invasive lobular 65 sarcosine 65 microemboli 65 sentinel nodes 65 precancers 65 contralateral breast 64 osteosarcomas 64 malignant growths 64 cell carcinomas 64 CIN3 + 64 polyp recurrence 64 pCR 64 lobular carcinomas 64 micrometastases 64 intact parathyroid hormone 64 GSTM1 64 cTnT 64 #ng/ml 64 pre cancerous lesions 64 atypical ductal hyperplasia 64 KRAS mutations occur 64 PSA nadir 64 malignant nodules 64 pre cancerous polyps 64 invasive carcinoma 64 basal cell nevus syndrome 64 rectal cancers 64 mutated K ras 64 prostate cancer CaP 64 lobular breast cancer 64 mucinous 64 necrotic core 64 HNSCC 64 benign nodules 64 basal cell cancers 64 epithelial tumors 64 definite stent thrombosis 64 papillomas 64 colorectal gastric 64 PASI scores 64 serum TSH 64 eosinophil count 64 adenomas 64 flutamide 64 recurrent VTE 64 pulmonary metastases 64 colorectal adenomas 64 serum urate levels 64 lung nodules 64 gastric adenocarcinoma 64 HER2 amplification 64 endometrial cancers 64 LV dysfunction 64 nonmelanoma skin cancer 64 gastric cardia 63 situ LCIS 63 colonic mucosa 63 PSADT 63 calcified plaques 63 mammographically 63 bowel polyps 63 coronary blockages 63 albumin excretion 63 basal cell carcinoma BCC 63 renal tumors 63 colon tumors 63 Radical prostatectomy 63 antibody titer 63 malignant lesions 63 complete cytogenetic response 63 lipid lowering medications 63 lactate dehydrogenase 63 mesotheliomas 63 MGUS 63 leiomyomas 63 cervical lesions 63 SUVmax 63 SLNB 63 malignant melanomas 63 prostate ovarian 63 telomere lengths 63 distant metastases 63 NNRTI resistance 63 adenoma recurrence 63 basal cell skin 63 lymph node involvement 63 skeletal metastases 63 HER2 positive cancers 63 cervical intraepithelial neoplasia 63 unresectable tumors 63 breast endometrial 63 neoplastic lesions 63 oesophageal squamous cell carcinoma 63 neutrophil counts 63 PCA3 scores 63 carotid artery thickness 63 carotid plaques 63 bladder cancers 63 TRUS biopsy 63 esophageal gastric 63 SHBG levels 63 seminomas 63 pulmonary dysfunction 63 BRAF mutations 63 GISTs 63 atherosclerotic lesions 63 differentiated thyroid 63 epididymal 63 neoplasias 63 elevated triglyceride levels 63 hemorrhagic complications 63 lung nodule 63 salpingo oophorectomy 63 recurrent venous thromboembolism 63 postoperative morbidity 63 abnormal cytology 63 adenocarcinomas 63 breast carcinoma 63 PCa 63 atheroma volume 63 K ras mutations 63 serum urate 63 dysglycemia 63 T2 lesions 63 carcinoids 63 squamous cell cancers 63 sitosterol 63 OGG1 63 ductal carcinomas 62 serum creatinine levels 62 transferrin saturation 62 premalignant lesions 62 lobular 62 underwent resection 62 papillary 62 hepatocellular carcinomas 62 Basal cell 62 intravenous bisphosphonates 62 axillary nodes 62 allogeneic HSCT 62 oral squamous cell 62 ASCUS 62 Cortisol levels 62 oesophageal adenocarcinoma 62 urate levels 62 biochemical recurrence 62 testicular tumors 62 perineural invasion 62 lymph node metastases 62 intima media thickness 62 systolic dysfunction 62 meningiomas 62 colorectal pancreatic 62 occult metastases 62 poor metabolizers 62 thyroid carcinoma 62 baseline LDH 62 clinically detectable 62 ischemic lesions 62 metastatic prostate 62 Polyps 62 premalignant 62 squamous cell lung cancer 62 urothelial carcinoma 62 LDL particle 62 precancerous tumors 62 micronuclei 62 colonic polyps 62 neoplasm 62 cardiac troponin T 62 underwent radical prostatectomy 62 bezafibrate 62 latent celiac disease 62 Squamous cell carcinomas 62 β blockers 62 liver metastases 62 prolonged QT interval 62 prostate walnut 62 calculi 62 urine cytology 62 ductal 62 antigen PSA levels 62 anterior uveitis 62 LDL cholesterol concentrations 62 TNF blocker therapy 62 radical nephrectomy 62 cellularity 62 endometrial thickness 62 hypertrophic scars 62 aminotransferase levels 62 adenomatous polyp 62 polyp detection 62 carotid stenosis 62 scintigraphic 62 anal lesions 62 mIU ml 62 p# mutation 62 lymph node metastasis 62 nonfasting triglyceride levels 62 precancerous cervical 62 hematopoietic cancers 62 asymptomatic carotid stenosis 62 ductal lobular 62 relapsed MM 62 ovarian carcinoma 62 pituitary adenomas 62 tibolone 62 HER2 overexpression 62 colon polyp 62 urothelial cancer 62 lung metastases 62 microbleeds 62 endometrioid 62 pancreatic prostate 62 bilateral oophorectomy 62 benign polyps 62 alanine aminotransferase ALT 62 intraoperative complications 62 arterial thickening 62 benign noncancerous 62 malignant prostate 62 urine albumin 61 oncologic outcomes 61 paricalcitol 61 hypermethylated 61 TMPRSS2 ERG fusion 61 HER2 positive tumors 61 NMIBC 61 endometrial carcinoma 61 carotid bruit 61 metaplasia 61 Barrett esophagus BE 61 nonmetastatic 61 CC genotype 61 cystoscopic 61 aminotransferases 61 seminoma 61 leiomyoma 61 Immunohistochemical staining 61 colorectal carcinomas 61 Leydig cell 61 grade cervical intraepithelial 61 liver metastasis 61 varicoceles 61 normal littermates 61 EUS FNA 61 Subgroup analyzes 61 cTnT levels 61 circulating endothelial cells 61 esophageal squamous cell carcinoma 61 metastatic lymph nodes 61 colorectal bowel 61 estrogen receptor negative 61 serum testosterone levels 61 postoperative infection 61 completely resected 61 glioma tumors 61 chromosomal alterations 61 submucosal 61 serum prostate 61 rebleeding 61 glomerular filtration 61 vaginal lesions 61 pT3 61 microdeletions 61 brain lesions 61 genital herpes infections 61 pT2 61 serum IgE 61 colon polyps 61 GBM tumors 61 myeloperoxidase 61 nucleotide substitutions 61 breast carcinomas 61 cutaneous melanoma 61 histologically 61 testicular cancers 61 gastric carcinoma 61 repigmentation 61 nonvertebral fracture 61 biochemical relapse 61 arterial stiffening 61 carcinoembryonic antigen 61 fibroadenomas 61 plasma folate 61 neuroblastoma tumors 61 thyroglobulin 61 GSTP1 61 serum calcium 61 Chlamydia infection 61 sarcomatoid 61 undergoing radical prostatectomy 61 lumbar disk herniation 61 esophageal tumors 61 Complication rates 61 CVD mortality 61 Baseline characteristics 61 cytological 61 nonproliferative 61 serum aminotransferase levels 61 System IPSS 61 lung ovary 61 atypia 61 troponins 61 MMSE scores 61 fibrin deposition 61 premalignant lesion 61 KRAS mutations 61 GnRH agonists 61 mIU L 61 glandular tissue 61 neurofibromas 61 resectable 61 Malignant tumors 61 tumor histology 61 intraductal 61 CHD mortality 61 schwannomas 61 hsCRP levels 61 pathologic examination 61 anaplastic 61 fetal chromosomal 61 FDG PET scans 61 #mmHg [001] 61 Histopathologic examination 61 hypervascular 61 highest tertile 61 mL/min/#.# m 2 61 elevated LDH 61 glycated hemoglobin levels 61 genital ulcers 61 chronic periodontitis 61 axillary 61 gastric cancers 61 triglyceride concentrations 61 μg L 61 ocular toxicity 61 alanine aminotransferase 61 obstructive coronary artery 61 nonischemic 61 Hemoccult II 61 melanoma lesions 61 ependymomas 60 node metastases 60 postmenopausal hormones 60 gadolinium enhanced 60 stent stenosis 60 colorectal cancer incidence 60 oropharyngeal cancer 60 mediastinal lymph nodes 60 ALA PDT 60 elevated hsCRP 60 postoperative complication 60 HbA 1c levels 60 parous women 60 BRCA2 mutations 60 tertile 60 lung adenocarcinomas 60 melanocytic nevi 60 pathologic diagnosis 60 axilla 60 elevated ALT 60 hemoglobin A1c levels 60 histologically confirmed 60 metastatic melanomas 60 CABG coronary artery 60 serum calcium levels 60 coronary stenosis 60 angiographic restenosis 60 anal cancers 60 axillary node dissection 60 squamous cell skin 60 adnexal mass 60 HIV HCV coinfected 60 NSTE ACS 60 FDG uptake 60 ADPKD 60 osteoid 60 proliferative diabetic retinopathy 60 serum testosterone 60 nonmelanoma 60 CD# expression [001] 60 endometrial biopsy 60 thromboembolic events 60 underwent surgical resection 60 urinary bladder cancer 60 clinically insignificant 60 alteplase 60 serum BDNF 60 noncalcified 60 HCV antibody 60 wound dehiscence 60 lung lesions 60 cranial irradiation 60 Triglyceride levels 60 creatinine ratio 60 external genital lesions 60 RAS mutations 60 neoplasms 60 renal cysts 60 pancreatic lung 60 μmol L 60 Legg Calvé Perthes disease 60 untreated celiac disease 60 epithelial ovarian 60 macroalbuminuria 60 varices 60 spontaneously regress 60 lesional 60 arterial occlusion 60 precancerous condition 60 benign moles 60 hormone receptor status 60 EGFR mutation 60 pancreatic endocrine 60 progesterone receptor negative 60 hepatic enzymes 60 total thyroidectomy 60 hamartoma 60 pre cancerous lesion 60 leukoplakia 60 epithelial ovarian cancer 60 telomerase inhibition 60 sentinel lymph node biopsy 60 fibrate drugs 60 Squamous 60 uterine cancers 60 MetS 60 vertebral fracture 60 basal cell 60 invasive ductal breast cancer 60 revascularization procedures 60 proton MR spectroscopy 60 venous blood clots 60 serrated polyps 60 atypical nevi 60 neurologic complications 60 prostate abnormalities 60 squamous cells 60 pmol L 60 Endometrial 60 mmol liter 60 sonographically 60 radical prostatectomy RP 60 infarcts 60 androgen excess 60 GSTT1 60 parotid 60 intravesical therapy 60 endometriosis ovarian cysts 60 ertapenem 60 tamoxifen Nolvadex ® 60 fetuin 60 ALK mutations 60 peritoneal cancer 60 lactate dehydrogenase LDH 60 homocysteine concentrations 60 dysplastic lesions 60 lymph node biopsies 60 Chlamydia trachomatis infection 60 cisplatin resistant 60 cancerous polyps 60 micrometastasis 60 cervical lymph nodes 60 cancerous colon polyps 60 ovarian endometrial 60 serum uric acid 60 paclitaxel eluting stents 60 heterozygotes 60 Papillary 60 nondiabetic patients 60 arterial thromboembolic events 60 A1c levels 60 postoperative chemotherapy 60 Circulating tumor cells 60 pleomorphic 60 squamous cell carcinomas 60 atypical lobular hyperplasia 60 Postoperative complications 60 BRCA1 mutations 60 oophorectomy 60 antitumor effect 60 neoadjuvant therapy 60 TT genotype 60 frequently benign tumor 60 TMPRSS2 ERG 60 ejection fractions 60 precancerous cervical lesions 60 CP CPPS 60 uterine tumors 60 HPV subtypes 60 atypical moles 60 cerebral microbleeds 60 transaminase levels 60 HBV infections 60 penetrance 60 Uterine cancer 60 curative resection 60 uveal melanoma 59 testicular germ cell 59 serum concentrations 59 underarm lymph nodes 59 Multivariate analyzes 59 caspofungin 59 nonalcoholic steatohepatitis NASH 59 BRCA1 mutation carriers 59 protein excretion 59 #OHD levels 59 TP# mutations 59 papilloma 59 pancreatic adenocarcinoma 59 nanomolar 59 tHcy 59 grade squamous intraepithelial 59 peritoneal carcinomatosis 59 intracranial atherosclerosis 59 carotid artery blockage 59 pg ml 59 echogenicity 59 nonnucleoside reverse transcriptase inhibitors 59 trophoblast cells 59 intracranial hemorrhage ICH 59 sentinel node 59 haemorrhagic stroke 59 GIST tumors 59 HER2 positivity 59 microvascular disease 59 acute HCV infection 59 tumor xenograft models 59 thymectomy 59 abnormal lipid levels 59 HbA1C levels 59 squamous carcinoma 59 CLA supplementation 59 esophageal cancers 59 Erythropoietic therapies may 59 carotid IMT 59 lung metastasis 59 axillary node 59 genital secretions 59 Hazard Ratio HR 59 CYT# potent vascular disrupting 59 urolithiasis 59 PBDE chemicals 59 thyroid hormone levels 59 squamous 59 papillary renal cell carcinoma 59 Adenomas 59 lymphocytosis 59 benign growths 59 KRAS mutation 59 melanoma tumors 59 thromboembolic complications 59 radiographically 59 antiandrogen 59 extracranial 59 apocrine 59 sCJD 59 dosing cohort 59 BCG vaccinated 59 recurrent ischemic stroke 59 medically inoperable 59 diverticular bleeding 59 recurrent metastatic 59 HOMA IR 59 PCNSL 59 p# mutations 59 pre cancerous 59 serum PTH 59 Ki# 59 prostate cancers 59 parenchymal 59 thrombi 59 fibroadenoma 59 elevated IOP 59 Plain radiographs 59 biliary tree 59 mammary tumors 59 beta carotene supplementation 59 solar keratosis 59 interferon beta therapy 59 ximelagatran 59 FluCAM arm 59 CCyR 59 endogenous estrogen 59 mesenteric 59 perioperative mortality 59 radiochemotherapy 59 mammographic density 59 femoral neck fracture 59 T. vaginalis 59 sleeve lobectomy 59 viral titers 59 lobular involution 59 macrophage infiltration 59 BCR ABL mutations 59 preoperative chemotherapy 59 chromosomal anomalies 59 kidney cysts 59 microscopic hematuria 59 premenopausal breast cancer 59 cardioembolic stroke 59 densest breasts 59 platelet reactivity 59 umol L 59 BRCA deficient 59 VATS lobectomy 59 tumoral 59 aortic atherosclerosis 59 BRAF mutation 59 non resectable metastatic 59 EGFR mutations 59 serum lipid levels 59 ovarian tumors 59 rs# [002] 59 oral antidiabetic medication 59 immunohistochemical 59 needle aspiration 59 attain statistical significance 59 Mitomycin C 59 gallstone disease 59 MSMB 59 urinary cadmium 59 prostate carcinomas 59 transaminase elevations 59 situ DCIS 59 cervical precancers 59 esophageal lesions 59 renal pelvis 59 localized renal 59 oesophageal 59 mmol l 59 hematologic toxicity 59 urinary albumin 59 Postoperatively 59 precancerous lesion 59 acute myocardial infarctions 59 BRCA2 mutation carriers 59 slow metabolizers 59 CMV infections 59 neovascular 59 axillary dissection 59 benign lesions 59 prostate tissue 59 resections 59 perimenopausal women 59 triacylglycerol concentrations 59 trabecular bone 59 thyrotropin 59 sUA 59 SETDB1 59 Inhibin B 59 tunica vaginalis 59 VTEs 59 pneumonectomy 59 UGT#A# * 59 8 OHdG 59 Prostate Specific Antigen PSA 59 endometrial lining 59 impair fertility 59 BRCA mutation carriers 59 dysplastic nevi 59 Hurthle cell 59 cerebral vasospasm 59 seropositivity 59 eccrine 59 Biopsies 59 gastric mucosa 59 ICDs implanted 59 oropharynx 59 subclinical cardiovascular disease 59 DEXA scans 59 phytoestrogen intake 59 endometrial ovarian 59 lymphadenectomy 59 undetectable PSA 59 cytologic 59 bronchoalveolar lavage 59 folic acid takers 59 CMV infection 59 fasting insulin 59 tracer uptake 59 breast lesions 59 cytoreduction 59 cTnI 59 hormone therapy estrogen 59 resected pancreatic cancer 59 invasive lobular carcinoma 59 colorectal cancer CRC 59 precancerous growths 59 thyroid carcinomas 59 vessel occlusion 59 deep venous thromboses 59 perioperative complications 59 TURP 59 gross hematuria 59 EGFR mutant 59 telangiectasia 59 vitamin K1 59 GBA mutations 59 symptomatic intracranial hemorrhage 59 upper endoscopy 59 core needle biopsies 59 plasma triglycerides 59 prostate TURP 59 precancerous polyps 59 astrocytomas 59 binary restenosis 59 T1a 59 PLX STROKE targeting 59 metastatic colorectal 59 endophthalmitis 59 onset diabetes mellitus 58 spirometric 58 thiazide diuretics 58 serum ferritin 58 lymphoid tumors 58 untreated metastatic melanoma 58 Hb A1c 58 excisional biopsy 58 chromosomal rearrangement 58 BMD measurements 58 S. aureus isolates 58 perfusion defect 58 invasive cervical cancers 58 catheter angiography 58 mmHg diastolic 58 anthracycline taxane 58 IOP lowering 58 intensive statin therapy 58 chorioamnionitis 58 Histological examination 58 cancerous breast 58 para aortic 58 male hormones androgens 58 pelvic lymph nodes 58 ovarian malignancy 58 SGPT 58 Homocysteine levels 58 protein albumin 58 opacification 58 prostate cancer PCa 58 immunostaining 58 albumin excretion rate 58 systolic blood pressures 58 thoracoscopic lobectomy 58 cerebral infarction 58 parasitaemia 58 ano genital warts 58 precancerous lesions 58 p# biomarker 58 lung adenocarcinoma 58 amyloid deposition 58 HbF 58 metastatic gastric 58 lung pancreatic 58 H. pylori eradication 58 estimated glomerular filtration 58 thrombotic complications 58 periodontal bacteria 58 transaminases 58 adnexal masses 58 coronary stenoses 58 atherosclerotic lesion 58 inguinal hernia repair 58 obstructive coronary 58 microcalcifications 58 lymphomas leukemias 58 precancerous tissues 58 overt hypothyroidism 58 serotonin synthesis 58 ABCB1 58 creatine kinase MB 58 ovulatory cycles 58 transfusion syndrome 58 stone formers 58 biopsy Gleason 58 CIN2 58 underwent coronary angiography 58 seminal vesicle invasion 58 sentinel lymph nodes 58 postoperative mortality 58 pancreatic lesions 58 conditional logistic regression 58 lymphovascular invasion 58 highest quintile 58 histologic subtypes 58 histological examination 58 renal toxicity 58 debulking surgery 58 H pylori 58 tumor recurrence 58 FDG PET imaging 58 colorectum 58 oropharyngeal 58 Melanomas 58 alkaline phosphatase ALP 58 PrPSc 58 presymptomatic 58 distant metastasis 58 polycystic ovary syndrome PCOS 58 resected 58 serum phosphate 58 operable breast cancer 58 dose ionizing radiation 58 atrophic gastritis 58 metastatic bladder 58 colorectal cancers 58 evaluable subjects 58 microsatellite instability 58 esophageal carcinoma 58 hip BMD 58 aspartate aminotransferase AST 58 benign proliferative breast 58 stratifying patients 58 reinterventions 58 histologic examination 58 adrenalectomy 58 atherogenic lipids 58 motor neuron degeneration 58 Flexi Scope 58 urothelial 58 varicocele 58 everolimus eluting stents 58 tumor necrosis 58 liver transplant recipients 58 KRAS oncogene 58 XIENCE V PROMUS Stent 58 nonobese 58 statistically significant correlations 58 histological subtypes 58 poorer prognosis 58 interferon alfa 2b 58 methylation markers 58 prostate glands 58 waist circumferences 58 lung resections 58 Ishak fibrosis score 58 gadobutrol 58 T1DM 58 surgical biopsies 58 IgA deficiency 58 bronchoalveolar 58 prostate adenocarcinoma 58 prospectively stratified 58 LRAT 58 subclinical disease 58 abnormal Pap 58 malignant lesion 58 orofacial clefts 58 carcinoid tumor 58 aromatase inhibitor therapy 58 haematologic 58 colorectal liver metastases 58 dysplastic lesions caused 58 folate concentrations 58 CYP#D# gene 58 CDI recurrence 58 familial pancreatic cancer 58 armpit lymph nodes 58 biopsy specimen 58 nonvertebral fractures 58 nonpregnant women 58 waist girth 58 microalbumin 58 5 HT2C receptor 58 prostate cancer metastases 58 resected tumors 58 noninfected 58 pulmonary metastasis 58 hyperinsulinemic euglycemic clamp 58 perfusion defects 58 nonobstructive CAD 58 serum IgG 58 noncancerous cells 58 Thyroid nodules 58 hepatectomy 58 MAGE A3 58 chemoembolization 58 RRM1 58 ALND 58 MCF7 cells 58 transurethral resection 58 aberrant crypt foci 58 BRAF V#E 58 Brain metastases 58 papillary carcinoma 58 primary hyperparathyroidism 58 histologic 58 symptomatic carotid stenosis 58 subclinical 58 plasma glucose levels 58 type2 diabetes 58 calcium oxalate 58 follicular thyroid cancer 58 geographic atrophy 58 plasminogen activators 58 chemoradiation therapy 58 esophagogastric junction 58 ipsilateral stroke 58 glomerular 58 ADAMTS# 58 leukocyte count 58 pelvic lymphadenectomy 58 hematological parameters 58 graft occlusion 58 tumor xenografts 58 anti HBs 58 wedge resection 58 LV hypertrophy 58 brain infarcts 58 radioiodine therapy 58 extracolonic findings 58 Immunohistochemical analysis 58 diastolic blood pressures 58 colorectal lung 58 immunocompetent 58 cholelithiasis 58 keratoses 58 enucleation 58 corticosterone levels 58 promoter methylation